The University of Southampton
University of Southampton Institutional Repository

Treating allergic rhinitis: continuous versus on-demand regime? Executive summary of the supportive initiatives for the global management of allergy (SIGMA): report from the Belgian working group

Treating allergic rhinitis: continuous versus on-demand regime? Executive summary of the supportive initiatives for the global management of allergy (SIGMA): report from the Belgian working group
Treating allergic rhinitis: continuous versus on-demand regime? Executive summary of the supportive initiatives for the global management of allergy (SIGMA): report from the Belgian working group
This Supportive Initiative for the Global Management of Allergy (SIGMA) initiative gathered together four multidisciplinary and inter-university groups of Belgian experts in the treatment of allergic rhinitis to review the literature and come to a consensus opinion on the global management of allergy. Their conclusions were as follows. Group 1 concluded that in children suffering from allergic rhinitis, there is sufficient expert opinion in favour of continuous treatment with both H1-antihistamines and corticosteroids for controlling symptoms during periods of allergen exposure, but not to support continuous treatment during periods when symptoms are negligible in an attempt to prevent the development of new allergic diseases. Group 2 came to similar conclusions in adults. Group 3 considered adults with concomitant asthma and stressed the crucial necessity to screen each asthmatic for allergic rhinitis and institute appropriate therapy for both conditions. Even though efficacious treatment algorithms are available for both rhinitis and asthma, an integrated management of these frequently concomitant diseases is not always prescribed even though there is a proven clinical advantage of adequate treatment of the nose of asthmatics. Group 4 concluded that for both H1-antihistamines and nasal corticosteroids, safety data indicate that continuous treatment may be given without fears of adverse consequences. With regard to the cost implications of continuous therapy versus on-demand therapy, there are indications that effective treatment of allergic rhinitis by continuous treatment reduces overall drug costs, particularly that of escape medication and indirect costs in the form of days absent from work and school.
1781-782X
1-25
Church, M.K.
dad189d5-866e-4ae1-b005-0d87f74282b8
Watelet, J.B.
805ea313-f46f-44a8-98e2-64109b12f14c
Belgian SIGMA Group
Church, M.K.
dad189d5-866e-4ae1-b005-0d87f74282b8
Watelet, J.B.
805ea313-f46f-44a8-98e2-64109b12f14c

Church, M.K. and Watelet, J.B. , Belgian SIGMA Group (2009) Treating allergic rhinitis: continuous versus on-demand regime? Executive summary of the supportive initiatives for the global management of allergy (SIGMA): report from the Belgian working group. B-ENT, 5 (S12), 1-25.

Record type: Article

Abstract

This Supportive Initiative for the Global Management of Allergy (SIGMA) initiative gathered together four multidisciplinary and inter-university groups of Belgian experts in the treatment of allergic rhinitis to review the literature and come to a consensus opinion on the global management of allergy. Their conclusions were as follows. Group 1 concluded that in children suffering from allergic rhinitis, there is sufficient expert opinion in favour of continuous treatment with both H1-antihistamines and corticosteroids for controlling symptoms during periods of allergen exposure, but not to support continuous treatment during periods when symptoms are negligible in an attempt to prevent the development of new allergic diseases. Group 2 came to similar conclusions in adults. Group 3 considered adults with concomitant asthma and stressed the crucial necessity to screen each asthmatic for allergic rhinitis and institute appropriate therapy for both conditions. Even though efficacious treatment algorithms are available for both rhinitis and asthma, an integrated management of these frequently concomitant diseases is not always prescribed even though there is a proven clinical advantage of adequate treatment of the nose of asthmatics. Group 4 concluded that for both H1-antihistamines and nasal corticosteroids, safety data indicate that continuous treatment may be given without fears of adverse consequences. With regard to the cost implications of continuous therapy versus on-demand therapy, there are indications that effective treatment of allergic rhinitis by continuous treatment reduces overall drug costs, particularly that of escape medication and indirect costs in the form of days absent from work and school.

This record has no associated files available for download.

More information

Published date: 2009
Additional Information: PubMed ID: 19475789

Identifiers

Local EPrints ID: 145633
URI: http://eprints.soton.ac.uk/id/eprint/145633
ISSN: 1781-782X
PURE UUID: a50d57bd-6001-4c53-bda6-0de1173f86e4

Catalogue record

Date deposited: 20 Apr 2010 09:00
Last modified: 07 Jan 2022 23:45

Export record

Contributors

Author: M.K. Church
Author: J.B. Watelet
Corporate Author: Belgian SIGMA Group

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×